시장조사 보고서 : 세계의 양극성 장애 약물 시장예측 2021년-2026년

■ 영문 제목 : Global Bipolar Disorder Drugs Market Growth 2021-2026
	■ 상품코드 : LPI-2108K202119 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 131 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 양극성 장애 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (기분 안정제, 항정신병제, 항우울제, 기타 약물)와 용도별 시장규모 (병원, 연구실, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 양극성 장애 약물 시장 점유율
- 지역별 양극성 장애 약물 시장규모
- 주요지역의 종류별 시장규모 (기분 안정제, 항정신병제, 항우울제, 기타 약물)
- 주요지역의 용도별 시장규모 (병원, 연구실, 기타)
- 미주의 양극성 장애 약물 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 양극성 장애 약물 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 양극성 장애 약물 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 양극성 장애 약물 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 양극성 장애 약물 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2020 growth of Bipolar Disorder Drugs will have significant change from previous year. By the most conservative estimates of global Bipolar Disorder Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Bipolar Disorder Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Bipolar Disorder Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Mood Stabilizers
Antipsychotic Drugs
Antidepressant Drugs
Other Drugs

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Lab
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
AstraZeneca
Bristol-Myers Squibb Company
Eli Lilly
Astellas Pharma
Allergan
Johnson & Johnson.
GlaxoSmithKline
AbbVie
Pfizer
Novartis

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bipolar Disorder Drugs Consumption 2016-2026
2.1.2 Bipolar Disorder Drugs Consumption CAGR by Region
2.2 Bipolar Disorder Drugs Segment by Type
2.2.1 Mood Stabilizers
2.2.2 Antipsychotic Drugs
2.2.3 Antidepressant Drugs
2.2.4 Other Drugs
2.3 Bipolar Disorder Drugs Sales by Type
2.3.1 Global Bipolar Disorder Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Bipolar Disorder Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Bipolar Disorder Drugs Sale Price by Type (2016-2021)
2.4 Bipolar Disorder Drugs Segment by Application
2.4.1 Hospital
2.4.2 Lab
2.4.3 Others
2.5 Bipolar Disorder Drugs Sales by Application
2.5.1 Global Bipolar Disorder Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Bipolar Disorder Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Bipolar Disorder Drugs Sale Price by Application (2016-2021)

3 Global Bipolar Disorder Drugs by Company
3.1 Global Bipolar Disorder Drugs Sales Market Share by Company
3.1.1 Global Bipolar Disorder Drugs Sales by Company (2019-2021)
3.1.2 Global Bipolar Disorder Drugs Sales Market Share by Company (2019-2021)
3.2 Global Bipolar Disorder Drugs Revenue Market Share by Company
3.2.1 Global Bipolar Disorder Drugs Revenue by Company (2019-2021)
3.2.2 Global Bipolar Disorder Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Bipolar Disorder Drugs Sale Price by Company
3.4 Global Manufacturers Bipolar Disorder Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bipolar Disorder Drugs Product Location Distribution
3.4.2 Players Bipolar Disorder Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Bipolar Disorder Drugs by Region
4.1 Global Bipolar Disorder Drugs by Region
4.1.1 Global Bipolar Disorder Drugs Sales by Region
4.1.2 Global Bipolar Disorder Drugs Revenue by Region
4.2 Americas Bipolar Disorder Drugs Sales Growth
4.3 APAC Bipolar Disorder Drugs Sales Growth
4.4 Europe Bipolar Disorder Drugs Sales Growth
4.5 Middle East & Africa Bipolar Disorder Drugs Sales Growth

5 Americas
5.1 Americas Bipolar Disorder Drugs Sales by Country
5.1.1 Americas Bipolar Disorder Drugs Sales by Country (2016-2021)
5.1.2 Americas Bipolar Disorder Drugs Revenue by Country (2016-2021)
5.2 Americas Bipolar Disorder Drugs Sales by Type
5.3 Americas Bipolar Disorder Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Bipolar Disorder Drugs Sales by Region
6.1.1 APAC Bipolar Disorder Drugs Sales by Region (2016-2021)
6.1.2 APAC Bipolar Disorder Drugs Revenue by Region (2016-2021)
6.2 APAC Bipolar Disorder Drugs Sales by Type
6.3 APAC Bipolar Disorder Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Bipolar Disorder Drugs by Country
7.1.1 Europe Bipolar Disorder Drugs Sales by Country (2016-2021)
7.1.2 Europe Bipolar Disorder Drugs Revenue by Country (2016-2021)
7.2 Europe Bipolar Disorder Drugs Sales by Type
7.3 Europe Bipolar Disorder Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Bipolar Disorder Drugs by Country
8.1.1 Middle East & Africa Bipolar Disorder Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Bipolar Disorder Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Bipolar Disorder Drugs Sales by Type
8.3 Middle East & Africa Bipolar Disorder Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Bipolar Disorder Drugs Distributors
10.3 Bipolar Disorder Drugs Customer

11 Global Bipolar Disorder Drugs Market Forecast
11.1 Global Bipolar Disorder Drugs Forecast by Region
11.1.1 Global Bipolar Disorder Drugs Forecast by Regions (2021-2026)
11.2.2 Global Bipolar Disorder Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Bipolar Disorder Drugs Forecast by Type
11.7 Global Bipolar Disorder Drugs Forecast by Application

12 Key Players Analysis
12.1 AstraZeneca
12.1.1 AstraZeneca AstraZeneca Company Information
12.1.2 AstraZeneca Bipolar Disorder Drugs Product Offered
12.1.3 AstraZeneca Bipolar Disorder Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AstraZeneca Main Business Overview
12.1.5 AstraZeneca Latest Developments
12.2 Bristol-Myers Squibb Company
12.2.1 Bristol-Myers Squibb Company Company Information
12.2.2 Bristol-Myers Squibb Company Bipolar Disorder Drugs Product Offered
12.2.3 Bristol-Myers Squibb Company Bipolar Disorder Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Bristol-Myers Squibb Company Main Business Overview
12.2.5 Bristol-Myers Squibb Company Latest Developments
12.3 Eli Lilly
12.3.1 Eli Lilly Company Information
12.3.2 Eli Lilly Bipolar Disorder Drugs Product Offered
12.3.3 Eli Lilly Bipolar Disorder Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Eli Lilly Main Business Overview
12.3.5 Eli Lilly Latest Developments
12.4 Astellas Pharma
12.4.1 Astellas Pharma Company Information
12.4.2 Astellas Pharma Bipolar Disorder Drugs Product Offered
12.4.3 Astellas Pharma Bipolar Disorder Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Astellas Pharma Main Business Overview
12.4.5 Astellas Pharma Latest Developments
12.5 Allergan
12.5.1 Allergan Company Information
12.5.2 Allergan Bipolar Disorder Drugs Product Offered
12.5.3 Allergan Bipolar Disorder Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Allergan Main Business Overview
12.5.5 Allergan Latest Developments
12.6 Johnson & Johnson.
12.6.1 Johnson & Johnson. Company Information
12.6.2 Johnson & Johnson. Bipolar Disorder Drugs Product Offered
12.6.3 Johnson & Johnson. Bipolar Disorder Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Johnson & Johnson. Main Business Overview
12.6.5 Johnson & Johnson. Latest Developments
12.7 GlaxoSmithKline
12.7.1 GlaxoSmithKline Company Information
12.7.2 GlaxoSmithKline Bipolar Disorder Drugs Product Offered
12.7.3 GlaxoSmithKline Bipolar Disorder Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 GlaxoSmithKline Main Business Overview
12.7.5 GlaxoSmithKline Latest Developments
12.8 AbbVie
12.8.1 AbbVie Company Information
12.8.2 AbbVie Bipolar Disorder Drugs Product Offered
12.8.3 AbbVie Bipolar Disorder Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 AbbVie Main Business Overview
12.8.5 AbbVie Latest Developments
12.9 Pfizer
12.9.1 Pfizer Company Information
12.9.2 Pfizer Bipolar Disorder Drugs Product Offered
12.9.3 Pfizer Bipolar Disorder Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Pfizer Main Business Overview
12.9.5 Pfizer Latest Developments
12.10 Novartis
12.10.1 Novartis Company Information
12.10.2 Novartis Bipolar Disorder Drugs Product Offered
12.10.3 Novartis Bipolar Disorder Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Novartis Main Business Overview
12.10.5 Novartis Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Bipolar Disorder Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Mood Stabilizers
Table 3. Major Players of Antipsychotic Drugs
Table 4. Major Players of Antidepressant Drugs
Table 5. Major Players of Other Drugs
Table 6. Global Bipolar Disorder Drugs Sales by Type (2016-2021) & (K MT)
Table 7. Global Bipolar Disorder Drugs Sales Market Share by Type (2016-2021)
Table 8. Global Bipolar Disorder Drugs Revenue by Type (2016-2021) & ($ million)
Table 9. Global Bipolar Disorder Drugs Revenue Market Share by Type (2016-2021)
Table 10. Global Bipolar Disorder Drugs Sale Price by Type (2016-2021)
Table 11. Global Bipolar Disorder Drugs Sales by Application (2016-2021) & (K MT)
Table 12. Global Bipolar Disorder Drugs Sales Market Share by Application (2016-2021)
Table 13. Global Bipolar Disorder Drugs Value by Application (2016-2021)
Table 14. Global Bipolar Disorder Drugs Revenue Market Share by Application (2016-2021)
Table 15. Global Bipolar Disorder Drugs Sale Price by Application (2016-2021)
Table 16. Global Bipolar Disorder Drugs Sales by Company (2019-2021) & (K MT)
Table 17. Global Bipolar Disorder Drugs Sales Market Share by Company (2019-2021)
Table 18. Global Bipolar Disorder Drugs Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Bipolar Disorder Drugs Revenue Market Share by Company (2019-2021)
Table 20. Global Bipolar Disorder Drugs Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Bipolar Disorder Drugs Producing Area Distribution and Sales Area
Table 22. Players Bipolar Disorder Drugs Products Offered
Table 23. Bipolar Disorder Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Bipolar Disorder Drugs Sales by Region (2016-2021) (K MT)
Table 27. Global Bipolar Disorder Drugs Sales Market Share by Region (2016-2021)
Table 28. Global Bipolar Disorder Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Bipolar Disorder Drugs Revenue Market Share by Region (2016-2021)
Table 30. Americas Bipolar Disorder Drugs Sales by Country (2016-2021) & (K MT)
Table 31. Americas Bipolar Disorder Drugs Sales Market Share by Country (2016-2021)
Table 32. Americas Bipolar Disorder Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Bipolar Disorder Drugs Revenue Market Share by Country (2016-2021)
Table 34. Americas Bipolar Disorder Drugs Sales by Type (2016-2021) & (K MT)
Table 35. Americas Bipolar Disorder Drugs Sales Market Share by Type (2016-2021)
Table 36. Americas Bipolar Disorder Drugs Sales by Application (2016-2021) & (K MT)
Table 37. Americas Bipolar Disorder Drugs Sales Market Share by Application (2016-2021)
Table 38. APAC Bipolar Disorder Drugs Sales by Region (2016-2021) & (K MT)
Table 39. APAC Bipolar Disorder Drugs Sales Market Share by Region (2016-2021)
Table 40. APAC Bipolar Disorder Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Bipolar Disorder Drugs Revenue Market Share by Region (2016-2021)
Table 42. APAC Bipolar Disorder Drugs Sales by Type (2016-2021) & (K MT)
Table 43. APAC Bipolar Disorder Drugs Sales Market Share by Type (2016-2021)
Table 44. APAC Bipolar Disorder Drugs Sales by Application (2016-2021) & (K MT)
Table 45. APAC Bipolar Disorder Drugs Sales Market Share by Application (2016-2021)
Table 46. Europe Bipolar Disorder Drugs Sales by Country (2016-2021) & (K MT)
Table 47. Europe Bipolar Disorder Drugs Sales Market Share by Country (2016-2021)
Table 48. Europe Bipolar Disorder Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Bipolar Disorder Drugs Revenue Market Share by Country (2016-2021)
Table 50. Europe Bipolar Disorder Drugs Sales by Type (2016-2021) & (K MT)
Table 51. Europe Bipolar Disorder Drugs Sales Market Share by Type (2016-2021)
Table 52. Europe Bipolar Disorder Drugs Sales by Application (2016-2021) & (K MT)
Table 53. Europe Bipolar Disorder Drugs Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Bipolar Disorder Drugs Sales by Country (2016-2021) & (K MT)
Table 55. Middle East & Africa Bipolar Disorder Drugs Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Bipolar Disorder Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Bipolar Disorder Drugs Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Bipolar Disorder Drugs Sales by Type (2016-2021) & (K MT)
Table 59. Middle East & Africa Bipolar Disorder Drugs Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Bipolar Disorder Drugs Sales by Application (2016-2021) & (K MT)
Table 61. Middle East & Africa Bipolar Disorder Drugs Sales Market Share by Application (2016-2021)
Table 62. Global Bipolar Disorder Drugs Sales Forecast by Type (2021-2026) & (K MT)
Table 63. Global Bipolar Disorder Drugs Sales Market Share Forecast by Type (2021-2026)
Table 64. Global Bipolar Disorder Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 65. Global Bipolar Disorder Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 66. Global Bipolar Disorder Drugs Sales Forecast by Application (2021-2026) & (K MT)
Table 67. Global Bipolar Disorder Drugs Sales Market Share Forecast by Application (2021-2026)
Table 68. Global Bipolar Disorder Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 69. Global Bipolar Disorder Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 70. AstraZeneca Basic Information, Bipolar Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 71. AstraZeneca Bipolar Disorder Drugs Product Offered
Table 72. AstraZeneca Bipolar Disorder Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 73. AstraZeneca Main Business
Table 74. AstraZeneca Latest Developments
Table 75. Bristol-Myers Squibb Company Basic Information, Bipolar Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Bristol-Myers Squibb Company Bipolar Disorder Drugs Product Offered
Table 77. Bristol-Myers Squibb Company Bipolar Disorder Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 78. Bristol-Myers Squibb Company Main Business
Table 79. Bristol-Myers Squibb Company Latest Developments
Table 80. Eli Lilly Basic Information, Bipolar Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Eli Lilly Bipolar Disorder Drugs Product Offered
Table 82. Eli Lilly Bipolar Disorder Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 83. Eli Lilly Main Business
Table 84. Eli Lilly Latest Developments
Table 85. Astellas Pharma Basic Information, Bipolar Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Astellas Pharma Bipolar Disorder Drugs Product Offered
Table 87. Astellas Pharma Bipolar Disorder Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 88. Astellas Pharma Main Business
Table 89. Astellas Pharma Latest Developments
Table 90. Allergan Basic Information, Bipolar Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Allergan Bipolar Disorder Drugs Product Offered
Table 92. Allergan Bipolar Disorder Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 93. Allergan Main Business
Table 94. Allergan Latest Developments
Table 95. Johnson & Johnson. Basic Information, Bipolar Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Johnson & Johnson. Bipolar Disorder Drugs Product Offered
Table 97. Johnson & Johnson. Bipolar Disorder Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 98. Johnson & Johnson. Main Business
Table 99. Johnson & Johnson. Latest Developments
Table 100. GlaxoSmithKline Basic Information, Bipolar Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. GlaxoSmithKline Bipolar Disorder Drugs Product Offered
Table 102. GlaxoSmithKline Bipolar Disorder Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 103. GlaxoSmithKline Main Business
Table 104. GlaxoSmithKline Latest Developments
Table 105. AbbVie Basic Information, Bipolar Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. AbbVie Bipolar Disorder Drugs Product Offered
Table 107. AbbVie Bipolar Disorder Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 108. AbbVie Main Business
Table 109. AbbVie Latest Developments
Table 110. Pfizer Basic Information, Bipolar Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer Bipolar Disorder Drugs Product Offered
Table 112. Pfizer Bipolar Disorder Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 113. Pfizer Main Business
Table 114. Pfizer Latest Developments
Table 115. Novartis Basic Information, Bipolar Disorder Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Novartis Bipolar Disorder Drugs Product Offered
Table 117. Novartis Bipolar Disorder Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 118. Novartis Main Business
Table 119. Novartis Latest Developments
List of Figures
Figure 1. Picture of Bipolar Disorder Drugs
Figure 2. Bipolar Disorder Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bipolar Disorder Drugs Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Bipolar Disorder Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Bipolar Disorder Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Mood Stabilizers
Figure 10. Product Picture of Antipsychotic Drugs
Figure 11. Product Picture of Antidepressant Drugs
Figure 12. Product Picture of Other Drugs
Figure 13. Global Bipolar Disorder Drugs Sales Market Share by Type in 2020
Figure 14. Global Bipolar Disorder Drugs Revenue Market Share by Type (2016-2021)
Figure 15. Bipolar Disorder Drugs Consumed in Hospital
Figure 16. Global Bipolar Disorder Drugs Market: Hospital (2016-2021) & (K MT)
Figure 17. Bipolar Disorder Drugs Consumed in Lab
Figure 18. Global Bipolar Disorder Drugs Market: Lab (2016-2021) & (K MT)
Figure 19. Bipolar Disorder Drugs Consumed in Others
Figure 20. Global Bipolar Disorder Drugs Market: Others (2016-2021) & (K MT)
Figure 21. Global Bipolar Disorder Drugs Sales Market Share by Application (2016-2021)
Figure 22. Global Bipolar Disorder Drugs Revenue Market Share by Application in 2020
Figure 23. Global Bipolar Disorder Drugs Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Bipolar Disorder Drugs Revenue Market Share by Company in 2020
Figure 25. Global Bipolar Disorder Drugs Sales Market Share by Regions (2016-2021)
Figure 26. Global Bipolar Disorder Drugs Revenue Market Share by Region in 2020
Figure 27. Americas Bipolar Disorder Drugs Sales 2016-2021 (K MT)
Figure 28. Americas Bipolar Disorder Drugs Revenue 2016-2021 ($ Millions)
Figure 29. APAC Bipolar Disorder Drugs Sales 2016-2021 (K MT)
Figure 30. APAC Bipolar Disorder Drugs Revenue 2016-2021 ($ Millions)
Figure 31. Europe Bipolar Disorder Drugs Sales 2016-2021 (K MT)
Figure 32. Europe Bipolar Disorder Drugs Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Bipolar Disorder Drugs Sales 2016-2021 (K MT)
Figure 34. Middle East & Africa Bipolar Disorder Drugs Revenue 2016-2021 ($ Millions)
Figure 35. Americas Bipolar Disorder Drugs Sales Market Share by Country in 2020
Figure 36. Americas Bipolar Disorder Drugs Revenue Market Share by Country in 2020
Figure 37. Americas Bipolar Disorder Drugs Sales Market Share by Type in 2020
Figure 38. Americas Bipolar Disorder Drugs Sales Market Share by Application in 2020
Figure 39. United States Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Bipolar Disorder Drugs Sales Market Share by Region in 2020
Figure 44. APAC Bipolar Disorder Drugs Revenue Market Share by Regions in 2020
Figure 45. APAC Bipolar Disorder Drugs Sales Market Share by Type in 2020
Figure 46. APAC Bipolar Disorder Drugs Sales Market Share by Application in 2020
Figure 47. China Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Bipolar Disorder Drugs Sales Market Share by Country in 2020
Figure 54. Europe Bipolar Disorder Drugs Revenue Market Share by Country in 2020
Figure 55. Europe Bipolar Disorder Drugs Sales Market Share by Type in 2020
Figure 56. Europe Bipolar Disorder Drugs Sales Market Share by Application in 2020
Figure 57. Germany Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Bipolar Disorder Drugs Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Bipolar Disorder Drugs Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Bipolar Disorder Drugs Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Bipolar Disorder Drugs Sales Market Share by Application in 2020
Figure 66. Egypt Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Bipolar Disorder Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles

※본 조사보고서 [세계의 양극성 장애 약물 시장예측 2021년-2026년] (코드 : LPI-2108K202119) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 양극성 장애 약물 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 항우울제 시장예측 2021년-2026년
LPI-2108K202103 / LP Information / 2021년 8월 / 본 조사보고서는 항우울제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Antidepressant Drugs will have significant change from previous year. By the most conservative estimates of global Antidepressant Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 12180 million in 2019. Over...

세계의 정신 장애 치료약 시장예측 2021년-2026년
LPI-2108K201578 / LP Information / 2021년 8월 / 본 조사보고서는 정신 장애 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Mental Disorders Drugs will have significant change from previous year. By the most conservative estimates of global Mental Disorders Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 당뇨병 치료약 시장예측 2021년-2026년
LPI-2108K202104 / LP Information / 2021년 8월 / 본 조사보고서는 당뇨병 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Antidiabetic Drugs will have significant change from previous year. By the most conservative estimates of global Antidiabetic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 생물학적 치료제 시장예측 2021년-2026년
LPI-2108K202118 / LP Information / 2021년 8월 / 본 조사보고서는 생물학적 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Biologic Therapeutics Drugs will have significant change from previous year. By the most conservative estimates of global Biologic Therapeutics Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 315410 million in...

세계의 고지혈증 처방약 시장예측 2021년-2026년
LPI-2108K201466 / LP Information / 2021년 8월 / 본 조사보고서는 고지혈증 처방약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Hyperlipidemia Prescription Drugs will have significant change from previous year. By the most conservative estimates of global Hyperlipidemia Prescription Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 입술 포진용 치료약 시장예측 2021년-2026년
LPI-2108K200023 / LP Information / 2021년 8월 / 본 조사보고서는 입술 포진용 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Herpes Labialis Drugs will have significant change from previous year. By the most conservative estimates of global Herpes Labialis Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 항비만약 시장예측 2021년-2026년
LPI-2108K200019 / LP Information / 2021년 8월 / 본 조사보고서는 항비만약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Anti Obesity Drugs will have significant change from previous year. By the most conservative estimates of global Anti Obesity Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 동물용 통증 관리약 시장예측 2021년-2026년
LPI-2108K201967 / LP Information / 2021년 8월 / 본 조사보고서는 동물용 통증 관리약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Veterinary Pain Management Drugs will have significant change from previous year. By the most conservative estimates of global Veterinary Pain Management Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 감량 치료제 시장예측 2021년-2026년
LPI-2108K200004 / LP Information / 2021년 8월 / 본 조사보고서는 감량 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Weight Loss Drugs will have significant change from previous year. By the most conservative estimates of global Weight Loss Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 항소화성 궤양 치료약 시장예측 2021년-2026년
LPI-2108K201064 / LP Information / 2021년 8월 / 본 조사보고서는 항소화성 궤양 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...